Technical Analysis for INDV - Indivior PLC

Grade Last Price % Change Price Change
F 17.78 0.45% 0.08
INDV closed up 0.45 percent on Wednesday, May 8, 2024, on 30 percent of normal volume.
Earnings due: May 9
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Flat

Date Alert Name Type % Chg
MACD Bullish Signal Line Cross Bullish 0.00%
Gapped Down Weakness 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.04%
Narrow Range Bar Range Contraction -2.04%
Inside Day Range Contraction -2.04%
Up 3 Days in a Row Strength -2.04%
Up 4 Days in a Row Strength -2.04%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.95%
Gapped Up Strength -0.95%
Up 3 Days in a Row Strength -0.95%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakout about 12 hours ago
Rose Above 10 DMA about 12 hours ago
Up 1% about 12 hours ago
Fell Below Previous Day's Low about 14 hours ago
Down 2 % 1 day ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet. The company operates in approximately 40 countries worldwide. It has collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Drugs Euphoriants Psychoactive Drugs Opioids Schizophrenia Morphinans Drug Rehabilitation Buprenorphine Opioid Use Disorder Sodium Channel Blockers

Is INDV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 24.8999
52 Week Low 14.3809
Average Volume 128,197
200-Day Moving Average 19.45
50-Day Moving Average 20.15
20-Day Moving Average 18.44
10-Day Moving Average 17.75
Average True Range 0.63
RSI (14) 38.27
ADX 24.61
+DI 17.90
-DI 28.93
Chandelier Exit (Long, 3 ATRs) 19.37
Chandelier Exit (Short, 3 ATRs) 19.00
Upper Bollinger Bands 20.07
Lower Bollinger Band 16.80
Percent B (%b) 0.3
BandWidth 17.73
MACD Line -0.67
MACD Signal Line -0.68
MACD Histogram 0.0105
Fundamentals Value
Market Cap 2.45 Billion
Num Shares 138 Million
EPS -0.40
Price-to-Earnings (P/E) Ratio -44.45
Price-to-Sales 0.00
Price-to-Book 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.37
Resistance 3 (R3) 18.34 18.13 18.27
Resistance 2 (R2) 18.13 17.98 18.14 18.23
Resistance 1 (R1) 17.95 17.89 18.04 17.98 18.20
Pivot Point 17.74 17.74 17.78 17.75 17.74
Support 1 (S1) 17.56 17.59 17.65 17.59 17.36
Support 2 (S2) 17.35 17.50 17.36 17.33
Support 3 (S3) 17.17 17.35 17.29
Support 4 (S4) 17.20